ENTITY

Odyssey Therapeutics (ODTX US)

9
Analysis
Health Care • United States
Clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology
more
Exchange Announcement • 05 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 04 Aug 2026 19:00

Current Report (Form 8-K | Period ending 2026-08-04)

Exchange Announcement • 23 Jun 2026 20:45

Current Report (Form 8-K | Period ending 2026-06-23)

Exchange Announcement • 18 Jun 2026 04:45

Current Report (Form 8-K | Period ending 2026-06-17)

Exchange Announcement • 17 Jun 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x